South Korea Compounding Pharmacies Market Size & Outlook, 2025-2033

South Korea Compounding Pharmacies Market Insights

Based on Reed Intelligence findings, the South Korea Compounding Pharmacies Market reached USD 130.28 Million in 2024 and is estimated to attain USD 219.98 Million by 2033.
From 2026 to 2033, the South Korea market is expected to grow at a steady CAGR of 5.96%.
Within the By Dosage Forms category, Solid Oral Preparations dominated in 2024 in terms of market size contribution.
Over the forecast period, Liquid Preparations is forecasted to deliver the fastest growth, positioning it as the most lucrative By Dosage Forms segment.

Other Key Findings

In 2024, South Korea represented 1.03% of the overall global Compounding Pharmacies Market size.
United States is projected to lead the global Compounding Pharmacies Market size by 2033.
Across Asia Pacific, China is anticipated to hold the dominant position in market size by 2033.
Taiwan is forecasted to expand at the fastest pace in Asia Pacific, attaining USD 284.49 Million by 2033.

Report Summary

Report Scope	Details
Base Year for Study	2024
Study Period	2021-2033
Historical Period	2021-2023
Forecast Period	2025-2033
Market Size In 2024	USD 130.28 Million
Market Size In 2033	USD 219.98 Million
Largest segment	Solid Oral Preparations
Units	Revenue in USD Million
CAGR	5.96% (2025-2033)
Segmnetation Covered
By Dosage Forms	Solid Oral Preparations Liquid Preparations Topical Ophthalmic Nasal Others
By Therapeutic Area	Hormone Replacement Therapy Pain Management Dermatology applications Specialty drugs Nutritional supplements Others
By Compounding Type	Pharmaceutical ingredient alteration (PIA) Pharmaceutical application alteration (PAA) Currently unavailable pharmaceutical manufacturing (CUPM) Pharmaceutical dosage alteration (PDA) Specialized animal pharmaceutical manufacturing (SAPM)
By End-User	Adult Pediatric Geriatric Veterinary
Report Coverage	Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends

South Korea Compounding Pharmacies Market By Dosage Forms 2025-2033 (USD Million)

By Dosage Forms	2021	2022	2023	2024	2025	2026	2027	2028	2029	2030	2031	2032	2033
Solid Oral Preparations	XX.x	XX.x	XX.x	40.84	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Liquid Preparations	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Topical	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Ophthalmic	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Nasal	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Others	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Total	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x

Source: RI Analysis Company Publications, Primary Interviews.

South Korea Compounding Pharmacies Market By Therapeutic Area 2025-2033 (USD Million)

By Therapeutic Area	2021	2022	2023	2024	2025	2026	2027	2028	2029	2030	2031	2032	2033
Hormone Replacement Therapy	XX.x	XX.x	XX.x	43.25	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Pain Management	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Dermatology applications	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Specialty drugs	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Nutritional supplements	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Others	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Total	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x

Source: RI Analysis Company Publications, Primary Interviews.

South Korea Compounding Pharmacies Market By Compounding Type 2025-2033 (USD Million)

By Compounding Type	2021	2022	2023	2024	2025	2026	2027	2028	2029	2030	2031	2032	2033
Pharmaceutical ingredient alteration (PIA)	XX.x	XX.x	XX.x	58.53	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Pharmaceutical application alteration (PAA)	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Currently unavailable pharmaceutical manufacturing (CUPM)	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Pharmaceutical dosage alteration (PDA)	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Specialized animal pharmaceutical manufacturing (SAPM)	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Total	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x

Source: RI Analysis Company Publications, Primary Interviews.

South Korea Compounding Pharmacies Market By End-User 2025-2033 (USD Million)

By End-User	2021	2022	2023	2024	2025	2026	2027	2028	2029	2030	2031	2032	2033
Adult	XX.x	XX.x	XX.x	53.18	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Pediatric	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Geriatric	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Veterinary	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Total	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x

Source: RI Analysis Company Publications, Primary Interviews.

Author :

Reed Intelligence Research Team

The Reed Intelligence Research Team brings together over 15+ years of collective experience in market research, data analytics, and strategic consulting. Comprising seasoned analysts, economists, and industry specialists, the team delivers precise, data-driven insights across sectors including technology, healthcare, energy, manufacturing, and consumer goods. By combining domain expertise with modern analytical tools, they ensure each report meets the highest standards of accuracy and relevance.